KEGG   PATHWAY: nle04928
Entry
nle04928                    Pathway                                
Name
Parathyroid hormone synthesis, secretion and action - Nomascus leucogenys (northern white-cheeked gibbon)
Description
Parathyroid hormone (PTH) is a key regulator of calcium and phosphorus homeostasis. The principal regulators of PTH secretion are extracellular ionized calcium (Ca2+) and 1,25-dihydroxyvitamin D (1,25(OH)2D3). Under conditions of dietary Ca restriction, a decrement in serum Ca concentration induces release of PTH from the parathyroid gland. PTH acts on bone and kidney to stimulate bone turnover, increase the circulating levels of 1,25(OH)2D3 and calcium and inhibit the reabsorption of phosphate from the glomerular filtrate. This hormone exerts its actions via binding to the PTH/PTH-related peptide receptor (PTH1R). PTH1R primarily activates two sub-types of heterotrimeric Gproteins: Gs and Gq , which in turn regulate the activity of adenylyl cyclases and phospholipase C (PLC) that control the flow of cAMP/PKA and IP/PKC signaling cascades, respectively.
Class
Organismal Systems; Endocrine system
Pathway map
nle04928  Parathyroid hormone synthesis, secretion and action
nle04928

Organism
Nomascus leucogenys (northern white-cheeked gibbon) [GN:nle]
Gene
100602462  CASR; extracellular calcium-sensing receptor isoform X2 [KO:K04612]
100588993  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [KO:K04630]
100583621  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
100604896  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 isoform X2 [KO:K04630]
100595636  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
100600367  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
100586735  ADCY3; adenylate cyclase type 3 isoform X2 [KO:K08043] [EC:4.6.1.1]
100603282  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
100580455  ADCY5; adenylate cyclase type 5 isoform X1 [KO:K08045] [EC:4.6.1.1]
100589304  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
100587036  ADCY7; adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
100592592  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
100599484  ADCY9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
100594473  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
100584446  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
100597115  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
100600507  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X3 [KO:K05858] [EC:3.1.4.11]
100606558  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
100600865  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
100587159  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
100599135  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X2 [KO:K04959]
100585914  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
100581967  GCM1; chorion-specific transcription factor GCMa [KO:K21598]
100605311  GCM2; chorion-specific transcription factor GCMb [KO:K21598]
100584411  MAFB; transcription factor MafB [KO:K09036]
100585545  GATA3; trans-acting T-cell-specific transcription factor GATA-3 isoform X1 [KO:K17895]
100585963  SP1; transcription factor Sp1 [KO:K04684]
100590313  VDR; vitamin D3 receptor isoform X1 [KO:K08539]
100585339  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
100580742  RXRB; retinoic acid receptor RXR-beta isoform X2 [KO:K08525]
100592610  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
100605361  FGF23; fibroblast growth factor 23 [KO:K22428]
100602423  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
100597454  KL; klotho [KO:K14756] [EC:3.2.1.31]
100600574  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100584480  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100590186  EGR1; early growth response protein 1 [KO:K09203]
100603580  PTH; parathyroid hormone isoform X2 [KO:K05261]
100586194  SGK1; serine/threonine-protein kinase Sgk1 isoform X3 [KO:K13302] [EC:2.7.11.1]
100595371  WNK2; LOW QUALITY PROTEIN: serine/threonine-protein kinase WNK2 [KO:K08867] [EC:2.7.11.1]
100594288  WNK1; serine/threonine-protein kinase WNK1 isoform X21 [KO:K08867] [EC:2.7.11.1]
100602576  WNK3; serine/threonine-protein kinase WNK3 [KO:K08867] [EC:2.7.11.1]
100605524  WNK4; serine/threonine-protein kinase WNK4 isoform X1 [KO:K08867] [EC:2.7.11.1]
100599412  OXSR1; serine/threonine-protein kinase OSR1 isoform X2 [KO:K08835] [EC:2.7.11.1]
100598685  STK39; STE20/SPS1-related proline-alanine-rich protein kinase isoform X1 [KO:K08835] [EC:2.7.11.1]
100591408  SLC12A3; solute carrier family 12 member 3 isoform X1 [KO:K14426]
100605550  PTHLH; parathyroid hormone-related protein isoform X1 [KO:K22608]
100583442  PTH1R; parathyroid hormone/parathyroid hormone-related peptide receptor isoform X1 [KO:K04585]
100591651  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
100590939  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
100601464  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
100596333  TRPV5; transient receptor potential cation channel subfamily V member 5 [KO:K04974]
100591728  SLC34A1; sodium-dependent phosphate transport protein 2A [KO:K14683]
100592949  SLC34A2; sodium-dependent phosphate transport protein 2B [KO:K14683]
100580485  SLC34A3; sodium-dependent phosphate transport protein 2C [KO:K14683]
100606650  SLC9A3R1; Na(+)/H(+) exchange regulatory cofactor NHE-RF1 [KO:K13365]
101176289  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoform X7 [KO:K04632]
115830355  neuroendocrine secretory protein 55 [KO:K04632]
100587050  PDE4D; cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X2 [KO:K13293] [EC:3.1.4.53]
100596792  PDE4A; cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform X4 [KO:K13293] [EC:3.1.4.53]
100599641  PDE4C; cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1 [KO:K13293] [EC:3.1.4.53]
100604983  PDE4B; cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform X2 [KO:K13293] [EC:3.1.4.53]
100583577  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X8 [KO:K04345] [EC:2.7.11.11]
100579779  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
100607741  PRKACG; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
100594622  25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial [KO:K07438] [EC:1.14.15.18]
100603459  1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1 [KO:K07436] [EC:1.14.15.16]
100589007  MEF2A; myocyte-specific enhancer factor 2A isoform X1 [KO:K09260]
100585129  MEF2C; myocyte-specific enhancer factor 2C isoform X1 [KO:K04454]
100583341  MEF2D; myocyte-specific enhancer factor 2D isoform X1 [KO:K09262]
100590543  SOST; sclerostin [KO:K16834]
100589731  NR4A2; nuclear receptor subfamily 4 group A member 2 isoform X1 [KO:K08558]
100579970  NACA; nascent polypeptide-associated complex subunit alpha isoform X1 [KO:K03626]
100598042  nascent polypeptide-associated complex subunit alpha-like [KO:K03626]
115837250  nascent polypeptide-associated complex subunit alpha, muscle-specific form-like [KO:K03626]
100606189  BGLAP; osteocalcin [KO:K22609]
100586389  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
100588313  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
100586647  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X2 [KO:K05870]
100582751  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
100603387  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
100595943  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
100594080  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
100597876  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
100592170  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
100588160  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
100600059  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
100598020  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta [KO:K09049]
100599838  TNFSF11; tumor necrosis factor ligand superfamily member 11 isoform X1 [KO:K05473]
100599011  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
100599083  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
100585899  FOS; proto-oncogene c-Fos [KO:K04379]
100588616  RUNX2; runt-related transcription factor 2 isoform X1 [KO:K09278]
100584961  MMP13; collagenase 3 isoform X2 [KO:K07994] [EC:3.4.24.-]
100591916  GNA12; guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
100589821  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
100581841  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
100587231  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
100582729  AKAP13; A-kinase anchor protein 13 [KO:K16529]
100607291  RHOA; transforming protein RhoA [KO:K04513]
100605600  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
100601695  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
100598721  ARRB1; beta-arrestin-1 isoform X1 [KO:K04439]
100599882  ARRB2; beta-arrestin-2 isoform X1 [KO:K04439]
100595311  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100582848  BRAF; serine/threonine-protein kinase B-raf isoform X2 [KO:K04365] [EC:2.7.11.1]
100582599  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100579506  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100606407  MMP14; matrix metalloproteinase-14 [KO:K07763] [EC:3.4.24.80]
100587495  MMP15; matrix metalloproteinase-15 [KO:K07995] [EC:3.4.24.-]
100583949  MMP16; matrix metalloproteinase-16 [KO:K07996] [EC:3.4.24.-]
100588007  MMP17; matrix metalloproteinase-17 [KO:K07997] [EC:3.4.24.-]
100606939  MMP24; matrix metalloproteinase-24 isoform X3 [KO:K08002] [EC:3.4.24.-]
100588853  MMP25; matrix metalloproteinase-25 [KO:K08003] [EC:3.4.24.-]
100600047  HBEGF; proheparin-binding EGF-like growth factor [KO:K08523]
100597255  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
Compound
C00009  Orthophosphate
C00020  AMP
C00076  Calcium cation
C00165  Diacylglycerol
C00575  3',5'-Cyclic AMP
C00698  Cl-
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C01561  Calcidiol
C01673  Calcitriol
C18231  Calcitetrol
Reference
  Authors
Khundmiri SJ, Murray RD, Lederer E
  Title
PTH and Vitamin D.
  Journal
Compr Physiol 6:561-601 (2016)
DOI:10.1002/cphy.c140071
Reference
  Authors
Bastepe M, Turan S, He Q
  Title
Heterotrimeric G proteins in the control of parathyroid hormone actions.
  Journal
J Mol Endocrinol 58:R203-R224 (2017)
DOI:10.1530/JME-16-0221
Reference
  Authors
Vilardaga JP, Romero G, Friedman PA, Gardella TJ
  Title
Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.
  Journal
Cell Mol Life Sci 68:1-13 (2011)
DOI:10.1007/s00018-010-0465-9
Reference
  Authors
Naveh-Many T, Silver J
  Title
Transcription factors that determine parathyroid development power PTH expression.
  Journal
Kidney Int 93:7-9 (2018)
DOI:10.1016/j.kint.2017.08.026
Reference
  Authors
Han SI, Tsunekage Y, Kataoka K
  Title
Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.
  Journal
Mol Cell Endocrinol 411:113-20 (2015)
DOI:10.1016/j.mce.2015.04.018
Reference
  Authors
Ferre S, Hoenderop JG, Bindels RJ
  Title
Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis.
  Journal
Kidney Int 82:1157-66 (2012)
DOI:10.1038/ki.2012.179
Reference
  Authors
Komaba H, Fukagawa M
  Title
FGF23-parathyroid interaction: implications in chronic kidney disease.
  Journal
Kidney Int 77:292-8 (2010)
DOI:10.1038/ki.2009.466
Reference
  Authors
Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F
  Title
Primary hyperparathyroidism.
  Journal
Nat Rev Dis Primers 2:16033 (2016)
DOI:10.1038/nrdp.2016.33
Reference
  Authors
de Groot T, Kovalevskaya NV, Verkaart S, Schilderink N, Felici M, van der Hagen EA, Bindels RJ, Vuister GW, Hoenderop JG
  Title
Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone.
  Journal
Mol Cell Biol 31:2845-53 (2011)
DOI:10.1128/MCB.01319-10
Reference
  Authors
Hernando N, Wagner C, Biber J, Murer H
  Title
Kidney kinase network regulates renal ion cotransport.
  Journal
J Clin Invest 117:3179-82 (2007)
DOI:10.1172/JCI33859
Reference
  Authors
Wang B, Means CK, Yang Y, Mamonova T, Bisello A, Altschuler DL, Scott JD, Friedman PA
  Title
Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.
  Journal
J Biol Chem 287:24148-63 (2012)
DOI:10.1074/jbc.M112.369405
Reference
  Authors
Crenshaw TD, Rortvedt LA, Hassen Z
  Title
Triennial Growth Symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization.
  Journal
J Anim Sci 89:1957-64 (2011)
DOI:10.2527/jas.2010-3411
Reference
  Authors
Zierold C, Mings JA, DeLuca HF
  Title
Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.
  Journal
Proc Natl Acad Sci U S A 98:13572-6 (2001)
DOI:10.1073/pnas.241516798
Reference
  Authors
Kramer I, Keller H, Leupin O, Kneissel M
  Title
Does osteocytic SOST suppression mediate PTH bone anabolism?
  Journal
Trends Endocrinol Metab 21:237-44 (2010)
DOI:10.1016/j.tem.2009.12.002
Reference
  Authors
Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H
  Title
Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
  Journal
J Bone Miner Res 22:1957-67 (2007)
DOI:10.1359/jbmr.070804
Reference
  Authors
Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T
  Title
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.
  Journal
Kidney Int 86:1106-15 (2014)
DOI:10.1038/ki.2014.215
Reference
  Authors
Pellicelli M, Hariri H, Miller JA, St-Arnaud R
  Title
Lrp6 is a target of the PTH-activated alphaNAC transcriptional coregulator.
  Journal
Biochim Biophys Acta 1861:61-71 (2018)
DOI:10.1016/j.bbagrm.2018.01.008
Reference
  Authors
Fu Q, Jilka RL, Manolagas SC, O'Brien CA
  Title
Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.
  Journal
J Biol Chem 277:48868-75 (2002)
DOI:10.1074/jbc.M208494200
Reference
  Authors
O'Brien CA
  Title
Control of RANKL gene expression.
  Journal
Bone 46:911-9 (2010)
DOI:10.1016/j.bone.2009.08.050
Reference
  Authors
Jilka RL
  Title
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.
  Journal
Bone 40:1434-46 (2007)
DOI:10.1016/j.bone.2007.03.017
Reference
PMID:8810350
  Authors
Pearman AT, Chou WY, Bergman KD, Pulumati MR, Partridge NC
  Title
Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.
  Journal
J Biol Chem 271:25715-21 (1996)
DOI:10.1074/jbc.271.41.25715
Reference
  Authors
Boumah CE, Selvamurugan N, Partridge NC
  Title
Transcription in the osteoblast: regulatory mechanisms utilized by parathyroid hormone and transforming growth factor-beta.
  Journal
Prog Nucleic Acid Res Mol Biol 80:287-321 (2005)
DOI:10.1016/S0079-6603(05)80007-8
Reference
  Authors
Hess J, Porte D, Munz C, Angel P
  Title
AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1  composite element.
  Journal
J Biol Chem 276:20029-38 (2001)
DOI:10.1074/jbc.M010601200
Reference
  Authors
Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH
  Title
G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells.
  Journal
Endocrinology 146:2171-5 (2005)
DOI:10.1210/en.2004-1283
Reference
  Authors
Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM
  Title
Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
  Journal
Mol Endocrinol 17:1607-21 (2003)
DOI:10.1210/me.2002-0040
Reference
  Authors
Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA
  Title
Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
  Journal
Am J Physiol Renal Physiol 292:F1028-34 (2007)
DOI:10.1152/ajprenal.00288.2006
Reference
  Authors
Agoro R, Ni P, Noonan ML, White KE
  Title
Osteocytic FGF23 and Its Kidney Function.
  Journal
Front Endocrinol (Lausanne) 11:592 (2020)
DOI:10.3389/fendo.2020.00592
Reference
  Authors
Erben RG, Andrukhova O
  Title
FGF23-Klotho signaling axis in the kidney.
  Journal
Bone 100:62-68 (2017)
DOI:10.1016/j.bone.2016.09.010
Reference
  Authors
Murillo-de-Ozores AR, Rodriguez-Gama A, Carbajal-Contreras H, Gamba G, Castaneda-Bueno M
  Title
WNK4 kinase: from structure to physiology.
  Journal
Am J Physiol Renal Physiol 320:F378-F403 (2021)
DOI:10.1152/ajprenal.00634.2020
Related
pathway
nle04012  ErbB signaling pathway
nle04020  Calcium signaling pathway
nle04024  cAMP signaling pathway
nle04310  Wnt signaling pathway
nle04380  Osteoclast differentiation
nle04961  Endocrine and other factor-regulated calcium reabsorption
KO pathway
ko04928   
LinkDB

DBGET integrated database retrieval system